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Mechanisms underlying 
heterologous skin scaffold-
mediated tissue remodeling
Kallyne K. O. Mimura1, Andréia R. Moraes2, Aline C. Miranda2, Rebecca Greco3, Tahera Ansari3, 
Paul Sibbons3, Karin V. Greco3,† & Sonia M. Oliani1,2,†
Biocompatibility of two newly developed porcine skin scaffolds was assessed after 3, 14, 21 and 90 days 
of implantation in rats. Both scaffolds showed absence of cells, preservation of ECM and mechanical 
properties comparable to non-decellularised skin before implantation. Host cell infiltration was much 
prominent on both scaffolds when compared to Permacol (surgical control). At day 3, the grafts were 
surrounded by polymorphonuclear cells, which were replaced by a notable number of IL-6-positive 
cells at day 14. Simultaneously, the number of pro-inflammatory M1-macrophage was enhanced. 
Interestingly, a predominant pro-remodeling M2 response, with newly formed vessels, myofibroblasts 
activation and a shift on the type of collagen expression was sequentially delayed (around 21 days). The 
gene expression of some trophic factors involved in tissue remodeling was congruent with the cellular 
events. Our findings suggested that the responsiveness of macrophages after non-crosslinked skin 
scaffolds implantation seemed to intimately affect various cell responses and molecular events; and this 
range of mutually reinforcing actions was predictive of a positive tissue remodeling that was essential 
for the long-standing success of the implants. Furthermore, our study indicates that non-crosslinked 
biologic scaffold implantation is biocompatible to the host tissue and somehow underlying molecular 
events involved in tissue repair.
Designed as a skin substitute, both epidermal and dermal acellular matrices (scaffolds) obtained after different 
decellularisation processes have been under investigation for over a decade1–5.
The choice of an appropriate scaffold is important to guide cell behavior, and cytotoxic products or materials 
that induce extensive scar formation should be avoided6. Differences in manufacturing techniques such as 
decellularization and crosslinking protocols can alter the physical characteristics of scaffolds7. To resist forces 
like wound contraction, scaffold materials - such as Permacol - are chemically crosslinked to enhance strength. 
However, because of lower cellular infiltration, extracellular matrix deposition, and neovascularization observed 
with Permacol, its use as a dermal substitute for wound healing has been reduced7. However, Permacol has been 
successfully used for hernia repair, pelvic floor reconstruction, urodynamic stress incontinence and rhinoplasty6.
Effective decellularisation methodology is dictated by factors such as cellular density, organization, clinical 
application and biologic properties of the extracellular matrix (ECM)8. ECM is highly conserved amongst species 
and consists of small proteins, growth factors, collagen and glycosaminoglycans (GAG)9 that are essential for 
providing the cell-to-matrix and cell-to-cell contacts, creating an ideal environment for new tissue growth or 
restoring homeostasis. Molecules present in the ECM signal cells directly or indirectly to trigger biological events 
and help orchestrate a sequence of events to promote proliferation and differentiation of the host derived cells10.
The mechanisms of ECM scaffold-mediated constructive remodeling are not fully understood. Cell recruit-
ment and the release of bioactive peptides by protease-mediated ECM degradation are thought to play a role in 
the constructive remodeling process and in wound healing11.
Wound healing is a complex, dynamic, multicellular process that involves several overlapping stages including 
inflammation, formation of granulation tissue, re-epithelialization and remodeling12. This process is regulated 
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by an equally complex signaling network involving numerous growth factors, chemokines and cytokines13,14. 
Transforming growth factor (TGF)-β , platelet-derived growth factor (PDGF), basic fibroblast growth factor 
(bFGF), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF) and the interleukin (IL) 
family12 are of particular interest amongst innumerous proteins present in the wound milieu.
The first phase of wound healing begins with capillary damage and clot formation. It is then followed by a 
number of events, including the production of pro-inflammatory cytokines and chemokines15, recruitment of 
inflammatory cells such as neutrophils and macrophages16, and also fibroblasts and endothelial cells17. In the 
second phase (proliferative phase), the process of neovascularization with delivery of nutrients and oxygen to 
the wound bed will contribute to fibroblast proliferation14. The fibroblasts become activated and, triggered by 
TGF-β 1, acquire a smooth muscle cell-like phenotype called myofibroblasts17,18. These cells exhibit contractile 
properties, due to the expression of alpha - smooth muscle actin (α -SMA) in microfilament bundles, playing a 
major role in the contraction and maturation of granulation tissue19. During the remodeling phase, the number 
of vascular cells and myofibroblasts are dramatically reduced by apoptosis20. In this scenario, the key orchestrators 
and effectors of the remodeling progression - macrophages - are known to alter their function and phenotype to 
meet the needs of the healing tissue21.
During the proliferative phase, macrophages assume a wide spectrum of different functional phenotypes 
that can influence repair22. The exact mechanisms are still poorly understood, but it has been thought that 
the macrophage phenotype switch during tissue remodeling may be driven, in part, by phagocytosis of tissue 
debris and apoptotic cells21. It has also been observed that transition between the pro-inflammatory (M1) to the 
anti-inflammatory (M2) phenotype is followed by a decrease in VEGF and pro-inflammatory cytokine produc-
tion (IL-1, IL-6), with an increase in IL-10 secretion23,24 and TGF-β 25.
In the context of regenerative medicine, the effect of macrophage phenotypes upon biologic scaffold remod-
eling has already been shown26. Our study however discuss the pleiotropic effect of macrophages upon different 
cell types and molecular responses evaluated by the host tissue reaction to two non-crosslinked skin scaffolds 
tailored by different decellularisation processes and one commercially available crosslinked dermal matrix well 
established for soft-tissue repair.
Results
Evaluation of scaffolds. Both decellularisation methods (described in Table 1) used to produce the acel-
lular matrices proved to be time (< 3 days) and cost-efficient, producing ‘off-the-shelf ’ skin scaffolds, which is 
very desirable in regenerative medicine. Following decellularisation, samples were assessed histologically using 
HE-stained sections. Figure 1A shows the histological structure of native porcine skin, whereas the scaffold 
revealed the complete removal of cells and nuclear material from the matrix (Fig. 1B,C). The collagen fibers of 
the scaffolds showed the classical collagen fiber architecture and distribution (Fig. 1E,F), when compared to the 
non-decellularised control skin (Fig. 1D). Furthermore, DNA quantification showed that approximately 90% of 
nuclear material was depleted after both decellularisation protocols, with no visible DNA on the electrophoresis 
gel following staining by ethidium bromide (Fig. 1G,H).
The ECM components of the bioengineered skin scaffolds were assessed by quantification of collagen and 
glycosaminoglycans (GAGs). Collagen content showed to be significantly decreased in the scaffolds 1 (100 ± 8 μ g 
collagen/mg tissue) when compared to control skin (134 ± 8 μ g collagen/mg tissue). This decrease was not sig-
nificant in the scaffold 2 (109 ± 8 μ g collagen/mg tissue) (Fig. 1I). The amount of GAGs (Fig. 1J) however was 
well-preserved after decellularisation (scaffold 1 = 16.04 ± 0.65 μ g; scaffold 2 = 16 ± 0.65; control = 16.52 ± 0.68 
GAGs/mg tissue).
The mechanical properties were evaluated in all the groups by tensile strength test, measured as the maximum 
stress that each sample could be stretched to withstand before breaking. The results showed that both decellular-
isation processes did not change the mechanical properties of the scaffolds when compared to the control group 
(Fig. 1K,L).
Histological analysis of acellular matrix and host tissues: biocompatibility. The porcine skin scaf-
folds (1 and 2) and Permacol were implanted subcutaneously in rats and its biocompatibility was assessed on the 
3°, 14° and 21° days.
Scaffold 1 Scaffold 2
Freezing (− 20 °C, 24 h) Freezing (− 20 °C, 24 h)
Wash buffera (2 × 12 h) Distilled H2O (6 h)
0.25% TritonX-100 + 0.25% SOC + 0.2 SA in distilled H2O (24 h) Hypertonic solutionc (overnight)
Wash buffer (2 × 12 h) Wash buffer (2 × 6 h)
Incubation bufferb + DNAse/RNAse (24 h) Hypotonic solutiond (overnight)
Wash buffer (2 × 12 h) Wash buffer (2 × 6 h)
Incubation buffer + DNAse/RNAse (24 h)
Wash buffer (2 × 6 h)
Table 1.  Reagents, concentrations, and time used for each decellularisation protocol. aWash buffer: PBS 
containing 0.05% Tween-20. bIncubation buffer: 400 mM Tris–HCl, 100 mM NaCl, 60 mM MgCl2, 10 mM 
CaCl2; pH 7.6. cHypertonic solution: 1 M NaCl, 10 mM EDTA, 50 mM Tris–HCl. dHypotonic solution: 5 mM 
EDTA, 10 mM Tris–HCl.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:35074 | DOI: 10.1038/srep35074
Histological analysis indicated that the implants were biocompatible, with no evidence of rejection or fibrosis. 
At day 3 of implantation, both scaffolds 1 and 2 were surrounded by an accumulation of polymorphonuclear 
(PMN) cells (Fig. 2A,E - insets); and from day 14, cell population was replaced by mononuclear cells, most likely 
macrophages and fibroblasts/ myofibroblasts distributed throughout both scaffolds (Fig. 2B–D,F–H - insets). 
Histologic appearance of the Permacol (used as surgical control) at day 3 after surgery showed a mild reaction 
of the host tissue and the cell infiltration was limited almost exclusively to the edge of the matrix, and slowly 
increased up to 90 days (Fig. 2I–L).
The collagen fibers of the scaffolds and Permacol were observed by picrosirius-haematoxylin polarization 
technique. At day 3 post-implantation, all implants displayed a uniform distribution of collagen fibers, which 
Figure 1. The acellular skin scaffolds produced by an enzymatic decellularisation method show preserved 
ECM components. Light microscopy analysis showing native porcine dermal matrix (A) and scaffolds 1 (B) 
and 2 (C). The collagen fibers of the scaffolds showed the classical collagen fiber architecture and distribution 
in both scaffolds (E,F), when compared to the non-decellularised control skin (D). Analysis of DNA naturally 
occurs in the normal skin and be absent in the scaffolds 1 and 2 (G,H). Quantitative analysis of collagen type 1 
(I) and glycosaminoglycans (GAGs) (J). Tensile strength test related to the mechanical properties of scaffolds  
(1 and 2) and control groups (K,B). Stain: Haematoxylin and Eosin (A–C); Picrosirius-haematoxylin and Miller 
Elastin (D–F). Data indicate the mean ± S.E.M. of DNA and collagen ng per mg of tissue (n = 5 samples/group). 
*p < 0.05 versus control; **p < 0.01 versus control.
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showed to be strongly birefringent under polarized light (Fig. 3A,E,I). In contrast, there was a significant decrease 
in collagen at the site of scaffold implantation at day 14 (Fig. 3B,F) when compared to day 3 (Fig. 3A,E), showing 
degradation and rearrangement of the matrices. Histologic appearance of a disorganized connective tissue from 
day 14 to 21 (Fig. 3B,C,F,G) and a significantly increased collagen deposition at day 90 (Fig. 3D,H), suggested that 
remodeling of connective tissue was taking place. The implanted Permacol matrices, however, were still identifi-
able throughout the study (Fig. 3I–L).
Cellular changes after scaffolds implantation: immunohistochemistry. The angiogenesis was ana-
lyzed by immune staining of the multimeric glycoprotein Von Willebrand factor (vWF) (Fig. 4A–C) in all scaf-
folds. The newly formed vessels were seen from day 14, with a significant increase at day 21 (Fig. 4D). While in 
Permacol there was no increase to over time (day 3 = 0; day 14 = 0; day 21 = 0.6 ± 0.2; day 90 = 2.5 ± 0.6).
Immunohistological methods were used to identify different cell populations during the remodeling process. 
IL-6 positive cells were quantified (Fig. 4E–G), and showed to be significantly increased in both scaffolds after day 
14 (scaffold 1 = 3099 ± 332; scaffold 2 = 2686 ± 238; p < 0.01), with progressive decrease in subsequent periods, 
when compared to Permacol (day 3 = 0; day 14 = 6 ± 2; day 21 = 9 ± 4; day 90 = 2 ± 1) (Fig. 4H).
Myofibroblasts, that are primarily responsible for wound contraction, have been identified by staining the 
cytoplasmic protein alpha-smooth muscle actin (α -SMA) (Fig. 4I–K), which is commonly used as a marker of 
myofibroblast differentiation. A marked increase of the α -SMA-positive cells was observed on day 21 (scaffold 
1 = 269 ± 29; scaffold 2 = 261 ± 29; p < 0.01), followed by an expressive reduction on day 90 (Fig. 4L).
To identify macrophage populations, surface markers CCR7 (M1 macrophages) and CD163 (M2 mac-
rophages) were used. Scaffolds 1 and 2 elicited predominately a CCR7+ response at day 14 (scaffold 1 = 217 ± 24; 
scaffold 2 = 218 ± 36; p < 0.01) (Fig. 5A,B,D), while CD163+ profile showed to be significantly increased only 
after day 21 (scaffold 1 = 512 ± 62; scaffold 2 = 439 ± 75; p < 0.001) (Fig. 5E,F,H), and persisted until day 90 in 
Figure 2. Histopathological evaluation performed after acellular matrix scaffolds implantation. Scaffolds 
without cross-linked 1 (A–D) and 2 (E–H), and Permacol with cross-linked (I–L) after days 3, 14, 21 and 90 of the 
surgical procedure. At day 3 of implantation, scaffolds 1 and 2 were surrounded by an accumulation of PMN cells 
(A,E - insets) and after day 14 were mostly mononuclear cells and myofibroblasts/fibroblasts (B–D,F–H - insets). 
Histologic appearance of the Permacol showed a mild reaction of the host tissue and limited cell infiltration (I–L). 
Host tissue (HT). Implant (Sc). Staining: Haematoxylin and Eosin.
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both scaffolds 1 and 2 (Fig. 5D,H). Permacol, in turn, showed the lowest population of mononuclear cells charac-
terized by a similar number of CCR7+ and CD163+ macrophages (Fig. 5C,D,G,H).
The ratio between M1/M2 phenotypes was calculated and showed in the Fig. 5I. Although the initial response 
to the scaffolds implantation showed a predominant inflammatory reaction (with values consistently above 1.0, 
which indicates a M1 macrophage response), the host tissue reaction seemed to equalize and displayed a promi-
nent M2-profile thereafter.
Molecular changes after scaffolds implantation: qRT-PCR. Gene modulation after implantation of 
scaffolds (1 and 2) and Permacol was assessed by fluorogenic qRT-PCR-based (TaqMan) assay. Scaffolds 1 and 2 
showed to trigger a strong inflammatory response seen by a substantial increase on the IL-1β mRNA expression, 
which started at day 3 (scaffold 1 = 9.2 ± 1 and scaffold 2 = 6.5 ± 1.9-fold increase; p < 0.001) and ceasing only 
around day 21 (scaffold 1 = 2 ± 1 and scaffold 2 = 1.6 ± 0.9 - fold increase) (Fig. 6A). Vascular endothelial growth 
factor A (VEGF-A) mRNA expression displays a bell-shaped curve with a significant augmented expression on 
Figure 3. Implants under polarized light showing naturally birefringent collagen fibers. Analyses of 
collagen fibers in the scaffolds 1 (A–D) and 2 (E–H), and Permacol (I–L) after days 3, 14, 21 and 90 of the 
surgical procedure. At day 3 post-implantation, all implants displayed a uniform distribution of collagen  
fibers (A,E,I). In contrast, histologic appearance shows a disorganized connective tissue from day 14 to 21 
(B,C,F,G) and a significantly increased collagen deposition at day 90 (D,H). The Permacol matrices were still 
identifiable throughout the study (I–L). Staining: picrosirius-haematoxylin.
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days 14 (scaffold 1 = 5.5 ± 0.7 and scaffold 2 = 6.7 ± 0.5 - fold increase; p < 0.01) (Fig. 6B). The expression of the 
transforming growth factor-beta 1 (TGF-β 1) however showed to be delayed, revealing a significant increase only 
at day 21 after implantation (Fig. 6C).
The marker genes for collagen remodeling COL1A1, COL1A2 and COL3A1 displayed an antagonist behavior. 
A marked increase on the collagen 3 (Fig. 6D) was seen at day 14 with a substantial decrease on day 21, when 
collagen 1 (COL1A1 and COL1A2; Fig. 6E,F) displayed its maximum expression (~8-fold increase in COL1A1 
and 7-fold increase in COL1A2).
Permacol did not stimulate significantly any of those classical markers of wound healing during the studied 
time points (Fig. 6A–F).
Discussion
Biologic scaffolds are commonly used to promote repair and restoration of functional tissues27. Although most, 
if not all of these scaffolds are composed of ECM or components of ECM, the clinical and tissue remodeling 
outcomes may differ greatly26. The bioactivity of scaffolds can be altered depending on the type of decellularisa-
tion reagents and processes used, eliciting distinct host-tissue morphologic and molecular responses. Models of 
wound healing in rodents can provide reliable and reproducible information on the response of wound contac-
tion to the experimental therapy28. Given the remarkable rate of advancement in wound healing in animal species, 
research may be able to develop more incisive models of the healing process and its key steps28,29.
In this study, we used a rat model to evaluate the cellular and molecular response to implantation of two decel-
lularised non-crosslinked porcine skin scaffolds in comparison to a commercially available crosslinked dermal 
scaffold (Permacol). Permacol has been used for years as a surgical implant, providing durability and strength for 
ventral hernia repair and abdominal wall reconstruction30,31.
The surgical sites at which the scaffolds were placed showed a dense infiltration of polymorphonuclear (PMN) 
and some mononuclear cells, which persisted up to day 21. A possible systemic reaction was discarded by meas-
uring leukocytes and inflammatory mediators in the blood of the animals after implantation (Supplementary 
Figure 1).
Figure 4. Analysis of angiogenesis and cell populations during the remodeling process. Immunohistochemical 
(day 14 representative image) and quantitative analysis of von Willebrand factor positive blood vessels (arrows) 
(A–D), IL-6 positive cells (arrows head) (E–H), and myofibroblasts (arrows head) (I–L) within the scaffolds  
(1 and 2) and Permacol at 3, 14, 21 and 90 days after implantation. Counterstaining: haematoxylin. Data indicate 
the mean ± S.E.M. of von Willebrand factor positive blood vessels and cells per cm2 (n = 5 animals/group). 
#p < 0.05 versus respective Permacol; ##p < 0.01 versus respective Permacol; ###p < 0.001 versus respective 
Permacol; *p < 0.05 versus day 3; ***p < 0.001 versus day 3; &p < 0.05 versus day 14; &&&p < 0.001 versus day 14; 
%p < 0.05 versus day 21; %%p < 0.01 versus day 21; %%%p < 0.001 versus day 21.
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Figure 5. Macrophages phenotypes modulation in scaffolds (1 and 2) and Permacol after implantation. 
Immunohistochemical (day 14 representative image) and quantitative analysis of CCR7 (A–D) and CD163  
(E–H) positive macrophages at 3, 14, 21 and 90 days. The insets show higher magnifications of the macrophages. 
Counterstaining: haematoxylin. Data indicate the mean ± S.E.M. cells per cm2 (n = 5 animals/group). #p < 0.05 
versus respective Permacol; ###p < 0.001 versus respective Permacol; *p < 0.05 versus day 3; ***p < 0.001 versus 
day 3; &p < 0.05 versus day 14; &&p < 0.01 versus day 14; &&&p < 0.001 versus day 14; %p < 0.05 versus day 21.
Figure 6. Gene expression of trophic factors involved in tissue remodeling. Scaffolds (1 and 2) and Permacol 
at 3, 14, 21 and 90 days were employed in the mRNA extraction with Trizol® reagent. The PCR reaction was 
performed with specific primers for the detection of mRNA levels of IL-1β (A), VEGF-A (B), TGF-β 1 (C), 
COL3A1 (D), COL1A1 (E) and COL1A2 (F). Data indicate the mean ± S.E.M. of mRNA relative expression 
(n = 5 animals/group). #p < 0.05 versus respective Permacol; ##p < 0.01 versus respective Permacol; ###p < 0.001 
versus respective Permacol; *p < 0.05 versus day 3; **p < 0.01 versus day 3; ***p < 0.001 versus day 3; &p < 0.05 
versus day 14; &&p < 0.01 versus day 14; &&&p < 0.001 versus day 14; %%p < 0.01 versus day 21.
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Both scaffolds displayed an uniform collagen remodeling when observed under polarized light 
(picrosirius-haematoxylin staining), but not the HDMI-crosslinked porcine dermal scaffold Permacol. 
Cross-linking agents, such as 1,6-hexamethylene diisocyanate (HDMI), are included in the processing of biologic 
materials to impart strength and to slow the degradation rate once implanted. Permacol being a crosslinked 
matrix could be distinctly seen with little reorganization of host connective tissue, and with insignificant infiltra-
tion of cells (IL-6-positive, macrophages and myofibroblasts) and blood vessels up to day 90. Our results are in 
agreement with other studies demonstrating that treatment with any crosslinking reagents can change the colla-
gen architecture at a molecular level32. These molecular alterations impact directly on cell surface interactions33, 
and can change the quantity and identity of secreted pro-inflammatory cytokines and chemokinesm34, the gene 
expression pattern35, and downstream remodeling events36,37. Kulig and collaborators (2013) showed that various 
non-crosslinked scaffolds commercially available, such as Alloderm, Gelfoam and Stattice, have lower cell migra-
tion and proliferation when compared to Permacol, despite of the latter being a crosslinked matrix. These results 
suggest that biologic and structural properties of both type of scaffolds need to be carefully studied to assess new 
products and its uses in this promising class of biomaterials38.
The non-crosslinked scaffolds 1 and 2 showed a similar degree of biocompatibility, with a pronounced cell 
infiltration from day 3 and much higher biodegradability when compared to Permacol. The angiogenic response 
was initiated on day 14, and at day 21 the number of newly formed vessels, visualized by immunostaining of von 
Willebrand factor (vWF), had significantly increased.
Although the non-crosslinked scaffolds 1 and 2 showed a similar degree of biocompatibility, a slightly delayed 
integration with host tissue, cellular infiltration and biodegradability was seen on scaffold 2 when compared to 
scaffold 1. Although these differences were not significant, they may be attributed to the loss of the glycosamino-
glycans (GAGs) content evidenced in the scaffold 1, probably caused by the reagents used in the decellularisation 
process. It has been shown that Triton-X, especially when combined with other detergents or enzymatic digestion 
(included in the manufacturing of scaffold 1), can lead to a certain loss on ECM components, resulting in early 
tissue degradation33.
The long-term remodeling outcome differs greatly amongst scaffold materials26. The maintenance of the ECM 
structure and biomechanical properties of the non-crosslinked scaffolds supported a satisfactory tissue remod-
eling when compared to the cross-linked Permacol. Nevertheless, depending on the particular application, it 
may be advantageous to use crosslinked scaffolds to limit the degree of subsequent scaffold degradation, which is 
crucial when scaffolds are intended to be used as permanent and non-absorbable matrices.
The temporal sequence of remodeling events of extracellular matrix devices, including the speed of scaffold 
degradation and the extent of new-tissue deposition by the host, may be predictive of the course of wound healing 
and outcome of the procedure27. In order for wounds to heal timely and properly, there must be a fine balance of 
interaction between various cell types, cytokines, growth factors, proteases and ECM components. Coordinated 
efforts of cells including leukocytes16, platelets, fibroblasts, endothelial cells14 and macrophages39,40 occur in order 
to promote formation of new tissue and wound closure.
In commonly used experimental models, the inflammatory phase is generally limited to the first few days after 
injury. Within hours after acute injury, inflammatory cells begin to accumulate at the affected site41. In common 
experimental models using healthy young male mice, neutrophil accumulation peaks around day 1 and returns 
to uninjured levels by days 5 to 10 after skin wounding42. The proliferative phase begins within days after injury 
and peaks within 1 week after injury; and the remodeling phase begins as proliferation starts to subside, and can 
last for months or more21.
Our results however indicated that, after skin scaffolds implantation, the remodeling process was somehow 
delayed. This could be attributed to an increased initial inflammatory response, which is clearly seen with an 
extensive infiltration of PMN cells and a concurrent amplified IL-1β mRNA expression, which showed a return to 
baseline conditions only after 14 days. This could have been caused by residues from reagents or components of 
the implanted scaffolds that could have directly or indirectly affected the cellular events. Collagen-based matrices 
have been used in several models for different medical applications43, but despite the desired effect, these mate-
rials can cause a relatively severe local inflammatory reaction after implantation, depending on the structure 
and functional characteristics of the material44. On the other hand, at a later stage our results did not show any 
complications related to the delayed proliferative phase, such as persistent inflammation or low-grade chronic 
inflammation, poor tissue organization, presence of foreign-body giant cells or fibrous encapsulation as shown 
by other authors45,46.
The different phases of wound healing is strictly regulated by multiple growth factors and cytokines14 that 
regulate migration, proliferation, and differentiation of cells47. Of particular interest, IL-6 has been shown to 
be important in the remodeling response12. Our results showed that IL-6 positive cells were increased at day 14 
and successively decreased thereafter. Those positive cells have the morphology of large mononuclear cells and 
we suggest that they may be monocytes that migrated into the tissue and started the transition into macrophage 
phenotypes. Sequential activation of classic, pro-inflammatory, M1 macrophages and alternatively activated or 
anti-inflammatory M2a, M2b, and M2c macrophages occurs during normal healing and facilitates transitions 
through the inflammatory, proliferative, and remodeling phases of repair22. Although morphologically indistin-
guishable using routine methods of examination, macrophages phenotypes can be identified and distinguished 
according to their cell surface markers and their cytokine and gene expression profiles26,48.
M1 phenotype (CCR7+ cells) accumulation occurred in our study on day 14. This is divergent with other 
studies showing that the M1 peak is somewhat earlier, around days 3 to 7, and declines significantly by days 10 to 
14, although low levels of macrophage accumulation may persist for weeks41,49,50.
Depletion of macrophages during the inflammatory phase reduces granulation tissue formation and cell pro-
liferation in mouse skin wounds39 and prevents formation of new myofibers in injured muscle51.
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Although the exact mechanisms by which macrophages regulate these processes remain to be determined, 
cytokine production may be one mechanism by which macrophages of the inflammatory phase initiate transition 
into the proliferative phase of healing26.
Interestingly, in our study we showed a timely gene expression shift marking this phenotype transition, which 
is in agreement with other authors24,52,53. mRNA expression of the vascular growth factor (VEGF-A) which 
showed to be strongly up-regulated until day 14, started subsiding as the transforming growth factor beta 1 
(TGF-β 1) gene expression began increasing. This was mirrored by an augmented number of CCR7+ (M1 mac-
rophages) at day 14 and a low number of CD163+ cells (M2 macrophages) observed at the implantation site. 
After day 14, however, the M1/M2 ratio indicated a predominant M2 response in both tested scaffolds.
Many growth factors and cytokines secreted by macrophages have pleiotropic influence on cell proliferation, 
angiogenesis, and extracellular matrix synthesis. To mention few, VEGF-A was shown to be strongly induced after 
cutaneous injury, with keratinocytes and macrophages being the major producers53. Its major function in wound 
healing is to promote cell differentiation and angiogenesis39,54. IL-6, also secreted by macrophages, initiates the 
healing response55 and induces regulation of proliferation of myofibroblasts24,56. And also, not less importantly, 
the TGF-β 1 that is known as the signature mediator of myofibroblasts differentiation57.
For successful wound healing, it is important that inflammation, angiogenesis and reepithelialization 
processes take place14,58,59. Non-crosslinked porcine skin scaffolds may allow the sequence of wound healing 
events to take place leading to an enhancing successful reepithelialization in skin wound models. According to 
Hoganson and collaborators (2010) the retention of a wide array of ECM proteins and cytokines makes those 
non-crosslinked matrices very promising assets showing potential advantages in some surgical applications. The 
retention of angiogenic growth factors and TGF-β suggests that those non-crosslinked matrices may support 
excellent fibroblast infiltration and collagen production when used for hernia repair and other surgical recon-
struction applications60.
In our study, the mRNA VEGF-A/TGF-β 1 switch seemed not only to hallmark the M1/M2 transition but also 
to overlap actions on myofibroblast differentiation, neovascularization and synthesis of different types of collagen. 
It has been shown that collagen deposition in skin wounds appears to be controlled by monocytes/macrophages 
of the inflammatory phase, rather than macrophages of later phases39,61. Although pronounced transcription of 
COL1α 1 and COL1α 2 can be up-regulated as early as 2 to 3 days after injury42,61, our results showed that those 
genes were up-regulated at day 21. Nonetheless, studies show that both early mRNA and late protein levels of 
collagen, when reduced by depletion of monocytes/macrophages during the inflammatory phase, seem to result 
in delayed healing but reduced scar formation52.
One of the characteristics of wound remodeling is the change of extracellular matrix composition. We therefore 
assessed the expression of the collagen marker genes COL1A1, COL1A2 and COL3A1 in response to skin scaf-
folds implantation and the results showed that the transition from collagen type III to I occurred around day 21, 
when we also see an increased number of myofibroblasts in the site of implantation.
Myofibroblasts are the predominant mediator of the contractile process because of their ability to extend and 
retract14. During granulation tissue formation, fibroblasts are gradually modulated into myofibroblasts, which are 
characterized by increased expression of smooth muscle differentiation markers such as alpha–smooth muscle 
actin (α -SMA), smooth muscle myosin, and desmin starting after the first week, and reaching a peak after day 1562.
Although there are many interconnected cells and molecular events to be further explored in more detail, 
our results suggest that modulation of myofibroblasts and ECM remodeling in the implantation site seems to be 
timely associated with the M2 response.
In the context of biomaterials, the large spectrum of events that underlines tissue homeostasis showed to 
be regarded, at least in part, to the well-known heterogeneity of macrophage phenotypes26,39. The relatively late 
responsiveness of those cells after non-crosslinked biological scaffolds implantation, in our study, seems to inti-
mately affect various other cell responses; and this range of mutually reinforcing actions was predictive of a pos-
itive tissue remodeling result.
The classical view of wound healing shows a timed sequence of cellular events directed largely by cytokines 
and growth factors that predicate the functional outcome of the newly formed tissue. Our study suggested 
that non-crosslinked biologic scaffold implantation somehow delayed the sequence of cell responsiveness and 
underlying molecular events involved in tissue repair. The late macrophage response seemed to modulate a net-
work of cellular events and molecular feedback, promoting a favorable remodeling response that is essential for 
long-standing success of the implant. Our data showed optimum biological properties of the non-crosslinked 
scaffolds, which may be useful tools as skin substitutes in reconstructive surgeries, and can also reduce morbidity, 
improving functional outcomes in clinical settings6.
Materials and Methods
Dermis harvesting and scaffold production. Fresh porcine skin was obtained from Large-White/
Landrace crossbreed pigs (6 months old) after euthanasia. Skin was cleansed with soap, shaved and washed with 
water and iodine based solution (10% w/w Cutaneous Solution - Iodinated Povidone, Videne, Garforth, UK). The 
intact skin (epidermis and dermis) was dissected from the animal’s flank, washed in sterile phosphate buffered 
saline (PBS, Sigma-Aldrich, Dorset, UK) with an antibiotic/ antimycotic solution (AA; Sigma-Aldrich, Dorset, 
UK) and stored in sterile plastic bags at − 20 °C for 24–48 h. The skin samples were defrosted, cut (2 × 2 cm), and 
allocated randomly into 2 groups for the production of decellularised scaffolds 1 and 2 (Table 1). This study was 
approved by Ethics Committee in Animal Experimentation of São Paulo State University (UNESP) (protocol no. 
062/2012 – CEUA) and was performed according to the regulatory guidelines of the UK Home Office.
Histological analysis of scaffolds. Samples from scaffolds (1 and 2) and Permacol (TSL, Hampshire, 
UK), a commercially available cross-linked porcine acellular dermis used as surgical control, were fixed for 24 h 
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in 10% NBF solution. They were washed, dehydration in graded alcohol, embedding in paraffin wax and sec-
tioned at 5 μ m. Separate sections were stained with Haematoxylin and Eosin (HE) and Picrosirius-haematoxylin 
(picrosirius-haematoxylin stained sections were analyzed under polarized light to assess degradation and tissue 
remodeling at the implantation site).
DNA quantification and gel electrophoresis of scaffolds. Samples were cut into small pieces, weighed 
and stored aseptically in DNA-free tubes. DNA was extracted following manufacturer’s instructions of GenElute 
mammalian genomic DNA miniprep kit (Sigma-Aldrich, Dorset, UK). Total DNA was quantitated by measuring 
the absorbance in a nano-drop spectrophotometer (NanoDrop ND1000, Thermo Scientific, Wilmington, USA), 
and the absolute amount of DNA per milligram of tissue was calculated.
The size, quality and purity of the extracted DNA were determined by electrophoresis. A 1.2% agarose 
(Agarose Type I, low EEO, Sigma-Aldrich, Dorset, UK) gel with 1x Tris-borate-ethylenediaminetetraacetic acid 
(TBE - Bio Reagent, 10x, Sigma-Aldrich, Dorset, UK) running buffer was run at 4 to 5 V/cm between the elec-
trodes. Equal volumes of DNA (5 μ L) and 1 μ L of loading buffer (5x DNA loading buffer, Yorkshire Bioscience 
Ltd., York, UK) were loaded into each well. Visualization was achieved by staining with 1% of ethidium bromide 
and DNA samples were measured via ultraviolet transllumination against a 1-kb DNA ladder (Q-Step 4 quantita-
tive DNA ladder, Yorkshire Bioscience Ltd., York, UK).
Glycosaminoglycan (GAG) quantification of scaffolds. To quantify GAG content on both scaffolds 
and control (non-decellularised skin), the Blyscan GAG assay kit (Biocolor, Carrickfergus, Northern Ireland) was 
used33. The absorbance was measured using a plate reader (Versamax, Molecular Devices LLC, USA) at 656 nm 
and the absolute GAG content was calculated per milligram of tissue.
Collagen quantification of scaffolds. Collagen was quantified using Sircol collagen assay kit (Biocolor, 
Carrickfergus, Northern Ireland)33. Extracts were placed in a 96-well plate in triplets and spectrophotometric 
readings were taken at 555 nm on a microplate reader (Versamax, Molecular Devices LLC, USA). Absolute values 
were attained with a standard curve composed of type I bovine skin collagen solution (0.5 mg/mL) in the range of 
5–100 μ g per 0.1 mL. Total collagen was normalized per milligram of tissue.
Biomechanical test of scaffolds. Mechanical properties of non-decellularised skin control and scaffolds 
1 and 2 (n = 5) were evaluated by a tensile strength test measured as the maximum stress that each sample could 
with stand whilst being stretched before reaching breaking point. For each test, specimens were cut into “dumb-
bell” shapes using a standard mold with 2.5 cm in length and 0.4 mm in width. The tests were performed with 
the application of uniaxial tension using a tensiometer (InstronInspec 220 Benchtop Portable tester, Instron, 
Buckinghamshire, UK). Samples were clamped into the holders and loaded at a constant tension rate. The tensile 
tester recorded the real-time load and elongation to which the tissue was subjected. Parameters such as maximum 
load (N), testing time (sec) and extension at maximum load (mm) were recorded. Strain was defined as rate of 
change of sample deformation and calculated as a ratio of the length at the maximum load to the original length; 
and stress was defined as how much load was applied at each meter squared sample. Young’s modulus (YM; MPa) 
was calculated by the ratio of stress (N/m2) over strain (%).
Experimental Animals. Male Wistar rats (250–300 g body weight), aged from 6 to 8 weeks old, were ran-
domly distributed into 9 groups (n = 5 per group) and kept in a 12 h light/dark cycle with food and water ad 
libitum.
Study Design. Both scaffolds and the control Permacol were cut (1 × 0.3 cm) and kept in saline prior to 
implantation. The animals were anesthetized with intramuscular administration of ketamine (100 mg/kg) and 
xylazine (10 mg/kg). The skin was shaved and cleaned using iodine based solution (10% w/w Cutaneous Solution 
- Iodinated Povidone, Videne, Garforth, UK). Ventral incisions (0.5 cm) were performed just inferior to the costal 
margin bilaterally. The subcutaneous tissue was dissected with scissors to expose a ‘pocket’ of approximately 1 cm 
where the scaffolds were placed. The scaffolds were positioned and fixed subcutaneously.
After 3, 14, 21 and 90 days after implantation, the animals (n = 5 for both tested scaffold and Permacol) were 
weighed and euthanized with an intra-peritoneal injection of sodium pentobarbitone. The scaffolds (Sc) as well 
as adjacent areas were collected and stored either in -80 °C or neutral buffer formalin (NBF).
Processing of skin fragments for histological analysis. The samples were processed for histology as 
described in “Histological analysis of scaffolds” session. Picrosirius-haematoxylin was used to enhance the natural 
birefringence of collagen and allow quantification of collagen fibers in the implantation site. HE staining was 
used for general assessment of the host tissue, implant integration, as well as general tissue reaction. An average 
of 5 fields were randomly selected and analyzed by two independent individuals using the commercial software 
Image-Pro Plus 6.0.
Immunohistochemical analysis. Sequential fragments of each specimen were cut at 4 μ m intervals. 
Representative sections of each sample were prepared for immunohistochemical staining by deparaffinization 
with xylene and rehydration through a graded ethanol series. Sections were submitted to an antigen retrieval 
step at 96 °C for 30 min, according to Table 2. The endogenous peroxide activity was blocked with 3% hydro-
gen peroxide for 30 min followed by a blocked with 10% BSA/PBS and an incubation with primary antibodies. 
Some sections were incubated with 1% BSA instead of the primary antibody to provide a negative control for 
the reaction. After washing, the sections were incubated with a secondary biotinylated Ab (Histostatin® Bulk 
Kit, Invitrogen, Frederick, MD, USA). Positive staining was detected using a peroxidase-conjugated streptavidin 
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complex and the color was developed using the DAB Substrate Kit (Invitrogen, Frederick, MD, USA). Finally, 
the sections were washed in distilled water, counterstained with haematoxylin. To assess neovascularization, the 
number of blood vessels stained for Von Willebrand factor (vWB) in the implanted scaffolds quantified and 
showed as mean ± SEM of the positive vessels per cm2 (5 random fields using a high-power objective x40). For 
all other immune-positive cells, data were expressed as cells per cm2 counted in 5 randomly selected fields. All 
sections were analyzed using an Axioskop 2-Mot Plus Microscope (Carl Zeiss, Jena, GR), and the AxioVision 
software for quantitative analysis.
The details of antigen retrieval, washing buffers and primary antibodies dilution are described in the Table 2.
Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR). Fluorogenic 
qRT-PCR-based (TaqMan) assay was used to detect amplification of the target genes. Briefly, total RNA was 
extracted using a commercially available kit (Qiagen RNeasy Mini Kit; Qiagen, Hilden, Germany), according 
to the manufacturer’s instructions, with the following modifications to minimize RNA degradation by abun-
dant skin RNAses. Samples were homogenized using bead-beating technology (Precellys, Bertin Technologies, 
Montigny-le-Bretonneux, France). Proteins potentially interfering with RNA isolation were removed by incubat-
ing the homogenate in 590 μ L distilled water and 5 μ L Proteinase K solution 20 mg/mL (Life Technologies, Paisley, 
UK) at 55 °C for 10 min then centrifuged at room temperature for 3 min. Supernatants were combined with 0.5 vol-
umes of ethanol (96–100%) into a Rnase-Dnase free tube and RNA was isolated through a RNeasy mini column. 
The concentration and purity of the RNA was analyzed using the Nandrop ND-1000 (NanoDrop Technologies, 
Wilmington, DE). All RNA samples were examined for their purity. The absorbance ratio at A260/A280 
nm of all samples was ranged from 1.85 to 2.1, indicating all the samples were pure during the RNA extraction 
procedure.
Complementary DNA (cDNA) was obtained by reverse transcription (RT) of 1 μ g of total RNA, with the 
Superscript III reverse transcriptase system (Invitrogen, Carlsbad, CA, USA) following the manufacturer’s pro-
tocol and using oligo(dT)15 as a primer. Real-time PCR was performed with the Eco Real-Time PCR System 
(Illumina, San Diego, CA, USA). The following amplification profile was used: UDG Incubation 50 °C for 2 min, 
AmpliTaq Gold 95 °C for 10 min, PCR 40 Cycles - 95 °C for 15 sec and 60 °C for 1 min. For each reaction, a total 
volume of 20 μ L was used, which consisted of 9 μ L of diluted cDNA (10 ng/μ L of RNA), 10 μ L of TaqMan Gene 
Expression Master Mix (2X) and 1 μ L of TaqMan Gene Expression Assay (20X) (Applied Biosystems, CA, USA). 
Commercially available primers (IL-1ß, Rn00580432_m1; TGF-ß1, Rn01475963_m1; VEGF-A, Rn01511604_m1; 
COL1A1, Rn01463870_g1; COL1A2, Rn00584426_m1; COL3A1, Rn01437683_m1 - Applied Biosystems, CA, 
USA) were used to probe for target mRNA.
Previous results showed that Hprt1 (Hypoxanthine phosphoribosyltransferase 1), CycA (Cyclophilin A), ACTs 
(actins) and Gapdh (Glyceraldehydes-3-phosphate dehydrogenase) are suitable potential reference genes for 
rats63. We therefore tested 3 of those potential reference genes (CycA, Actb and Gapdh) for validation of their gene 
expression stability and suitability as internal controls according to the requirements of the MIQE Guidelines. 
Our preliminary tests for the reference genes showed that although some genes that are implicated in basal cell 
metabolism may not be stable upon different conditions64, Gapdh amongst the other reference genes displayed the 
narrowest expression range with cycle threshold values between 23 and 25 (Ct = 24 ± 1.5). This gene had a very 
stable expression in all the experimental conditions along with comparable expression characteristics to target 
genes. For this reason the use of Gapdh alone as a reference gene shown in our study was sufficient. mRNA was 
then normalized relative to Gapdh (GAPDH, Rn01462662_g1; Applied Biosystems, CA, USA), which was subse-
quently used to calculate expression levels of the target genes. The comparative Ct method was used to measure 
the gene transcription in samples65. Results were expressed as relative units based on calculation of 2-Δ Δ Ct, 
which gives the relative amount of target gene normalized to endogenous control (GAPDH) and to the control 
(sham-operated) samples with the expression set as 1. Negative controls were either RT without enzyme or PCR 
without cDNA template.
Statistical analysis. Results were shown as mean ± SEM. For samples with normal distribution, analysis 
of variance (ANOVA) was used for repeated measures followed by the Bonferroni test. The Kruskal-Wallis test 
followed by Dunn’s test was used for samples with non-normal distribution. Statistical significance was defined 
as p < 0.05.
Antigen retrieval Washing buffer Primary antibody reference
Primary antibody 
dilution
vWF TRIS-EDTA buffer pH 9 PBS
polyclonal rabbit anti-Human Von 
Willebrand Factor (Dako, Glostrup, 
Netherland)
1:200 in BSA1%, for 
1 h at RT
IL-6 10 mM sodium citrate buffer pH 6 PBS monoclonal anti-IL-6 (840234, R&D, Minneapolis, USA)
1:100 in BSA1%, for 
1 h at RT
Myofibroblast 10 mM sodium citrate buffer pH 6 TBS Polyclonal rabbit anti-α -SMA (Dako, Glostrup, Netherlands)
1:500 in BSA1%, 
overnight at 4 °C
CCR7–M1 10 mM sodium citrate buffer pH 6 TBS Monoclonal rabbit anti- CCR7 (Novus Biologicals, Littleton CO, USA)
1:500 in 1% BSA, for 
1 h at RT
CD163–M2 10 mM sodium citrate buffer pH 6 PBS Monoclonal rabbit anti- CD163 (Hycult Biotech, Uden, Netherlands)
1:500 in 1% BSA, for 
1 h at RT
Table 2.  Solutions and incubation times for IHC protocols.
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